Ideaya Biosciences, Inc. (IDYA) SEC Filing 8-K Material Event for the period ending Monday, September 30, 2019

Ideaya Biosciences, Inc.

CIK: 1676725 Ticker: IDYA

View differences made from one to another to evaluate Ideaya Biosciences, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Ideaya Biosciences, Inc..


Assess how Ideaya Biosciences, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Ideaya Biosciences, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


Ticker: IDYA
CIK: 1676725
Form Type: 8-K Corporate News
Accession Number: 0001193125-19-262981
Submitted to the SEC: Fri Oct 04 2019 9:45:36 PM EST
Accepted by the SEC: Mon Oct 07 2019
Period: Monday, September 30, 2019
Industry: Pharmaceutical Preparations
  1. New Agreement
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: